188 related articles for article (PubMed ID: 33389743)
1. [Treatment of chromoblastomycosis and phaeohyphomycosis].
Dobiáš R; Havlíček V
Klin Mikrobiol Infekc Lek; 2020 Jun; 26(2):62-68. PubMed ID: 33389743
[TBL] [Abstract][Full Text] [Related]
2. [Chromoblastomycosis and phaeohyphomycosis - pathogenesis and laboratory diagnosis].
Dobiáš R; Havlíček V
Klin Mikrobiol Infekc Lek; 2020 Jun; 26(2):69-75. PubMed ID: 33389744
[TBL] [Abstract][Full Text] [Related]
3. Melanized fungal infections in kidney transplant recipients: contributions to optimize clinical management.
Santos DW; Camargo LF; Gonçalves SS; Ogawa MM; Tomimori J; Enokihara MM; Medina-Pestana JO; Colombo AL
Clin Microbiol Infect; 2017 May; 23(5):333.e9-333.e14. PubMed ID: 28062320
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment with isavuconazole of subcutaneous phaeohyphomycosis in a kidney transplant recipient.
Dalla Gasperina D; Lombardi D; Rovelli C; Di Rosa Z; Lepera V; Baj A; Nava A; Lombardi G; Grossi PA
Transpl Infect Dis; 2019 Dec; 21(6):e13197. PubMed ID: 31617282
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous mycoses. Part 1: subcutaneous mycoses due to non-dermatophytes.
Romano C
G Ital Dermatol Venereol; 2013 Dec; 148(6):621-31. PubMed ID: 24442042
[TBL] [Abstract][Full Text] [Related]
6. [Chromoblastomycosis and phaeohyphomycosis, overlooked fungal diseases].
Dobiáš R; Havlíček V
Klin Mikrobiol Infekc Lek; 2020 Jun; 26(2):54-61. PubMed ID: 33389742
[TBL] [Abstract][Full Text] [Related]
7. From phaeohyphomycosis to disseminated chromoblastomycosis: A retrospective study of infections caused by dematiaceous fungi.
Thomas E; Bertolotti A; Barreau A; Klisnick J; Tournebize P; Borgherini G; Zemali N; Jaubert J; Jouvion G; Bretagne S; Picot S
Med Mal Infect; 2018 Jun; 48(4):278-285. PubMed ID: 29656841
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic management of subcutaneous phaeohyphomycosis and chromoblastomycosis in kidney transplant recipients: a retrospective study of 82 cases in a single center.
Lima ACC; Santos DWCL; Hirata SH; Nishikaku AS; Enokihara MMSES; Ogawa MM
Int J Dermatol; 2022 Mar; 61(3):346-351. PubMed ID: 34633082
[TBL] [Abstract][Full Text] [Related]
9. Antifungal efficacy of isavuconazole and liposomal amphotericin B in a rabbit model of Exserohilum rostratum meningoencephalitis: A preclinical paradigm for management of CNS phaeohyphomycosis.
Petraitis V; Petraitiene R; Katragkou A; Maung BBW; Moradi PW; Sussman-Straus GE; Naing E; Kovanda LL; Finkelman MA; Walsh TJ
Med Mycol; 2021 Feb; 59(2):189-196. PubMed ID: 33313821
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous dematiaceous fungal infection.
Patel U; Chu J; Patel R; Meehan S
Dermatol Online J; 2011 Oct; 17(10):19. PubMed ID: 22031645
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous phaeohyphomycosis caused by Alternaria section Alternaria.
Xia X; Liu Z; Shen H
Int J Infect Dis; 2023 Sep; 134():99-101. PubMed ID: 37268101
[TBL] [Abstract][Full Text] [Related]
12. New possibilities for chromoblastomycosis and phaeohyphomycosis treatment: identification of two compounds from the MMV Pathogen Box® that present synergism with itraconazole.
Coelho RA; Alves GM; Figueiredo-Carvalho MHG; Almeida-Silva F; de Souza GR; Lourenço MCDS; Brito-Santos F; Amaral ACF; Almeida-Paes R
Mem Inst Oswaldo Cruz; 2022; 117():e220089. PubMed ID: 36102413
[TBL] [Abstract][Full Text] [Related]
13. Posaconazole treatment of refractory eumycetoma and chromoblastomycosis.
Negroni R; Tobón A; Bustamante B; Shikanai-Yasuda MA; Patino H; Restrepo A
Rev Inst Med Trop Sao Paulo; 2005; 47(6):339-46. PubMed ID: 16553324
[TBL] [Abstract][Full Text] [Related]
14. Successful sequential treatment with itraconazole and ALA-PDT for chromoblastomycosis because of Alternaria alternata.
Liu ZH; Xia XJ
Dermatol Ther; 2014; 27(6):357-60. PubMed ID: 25039437
[TBL] [Abstract][Full Text] [Related]
15. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi.
Chowdhary A; Meis JF; Guarro J; de Hoog GS; Kathuria S; Arendrup MC; Arikan-Akdagli S; Akova M; Boekhout T; Caira M; Guinea J; Chakrabarti A; Dannaoui E; van Diepeningen A; Freiberger T; Groll AH; Hope WW; Johnson E; Lackner M; Lagrou K; Lanternier F; Lass-Flörl C; Lortholary O; Meletiadis J; Muñoz P; Pagano L; Petrikkos G; Richardson MD; Roilides E; Skiada A; Tortorano AM; Ullmann AJ; Verweij PE; Cornely OA; Cuenca-Estrella M; ;
Clin Microbiol Infect; 2014 Apr; 20 Suppl 3():47-75. PubMed ID: 24483780
[TBL] [Abstract][Full Text] [Related]
16. Difficult mycoses of the skin: advances in the epidemiology and management of eumycetoma, phaeohyphomycosis and chromoblastomycosis.
Garnica M; Nucci M; Queiroz-Telles F
Curr Opin Infect Dis; 2009 Dec; 22(6):559-63. PubMed ID: 19773651
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous phaeohyphomycosis: infection with pigmented fungi.
Soomro IN; Kennedy A
J Pak Med Assoc; 1996 Jul; 46(7):156-8. PubMed ID: 8993045
[No Abstract] [Full Text] [Related]
18. Dematiaceous Molds.
Wong EH; Revankar SG
Infect Dis Clin North Am; 2016 Mar; 30(1):165-78. PubMed ID: 26897066
[TBL] [Abstract][Full Text] [Related]
19. Doubly Misdiagnosed: Exophiala Masquerading as Squamous Cell Carcinoma and Chromoblastomycosis.
Guerra R; Guffey D; Russell M
Am J Dermatopathol; 2022 Jan; 44(1):e8-e10. PubMed ID: 34086642
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous phaeohyphomycosis of the face presenting as rhinoentomophthoramycosis.
Mahajan VK; Chauhan PS; Mehta KS; Abhinav C; Sharma V; Thakur K
Int J Dermatol; 2013 Sep; 52(9):1105-8. PubMed ID: 23834722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
